Search research articles
Contact Us
Filters
Showing results (301-310 of 342) with videos related to
Page
of 35
Sort By:
Blood
|
April 25, 2025
A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed/refractory multiple myeloma
Sarah A Holstein, Shebli Atrash, Hira Mian, et al.
Haematologica
|
March 15, 2015
Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide
Michel Delforge, Leonard Minuk, Jean-Claude Eisenmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma
Ravi Vij, Shaji Kumar, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2024
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival
Marcelo C Pasquini, Paul K Wallace, Brent Logan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2009
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia
Alexander E Perl, Margaret T Kasner, Donald E Tsai, et al.
The Lancet. Oncology
|
October 4, 2011
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial
Amrita Krishnan, Marcelo C Pasquini, Brent Logan, et al.
Osteoarthritis and Cartilage
|
September 9, 2018
The role of NOX2-derived reactive oxygen species in collagenase-induced osteoarthritis
S C M van Dalen, N N L Kruisbergen, B Walgreen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2019
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Edward A Stadtmauer, Marcelo C Pasquini, Beth Blackwell, et al.
Leukemia
|
November 2, 2011
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
A Mahindra, M E Kalaycio, J Vela-Ojeda, et al.
Clinical Chemistry
|
August 12, 2021
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking
Hui Chen, Zhao Li, Sheng Feng, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 342) with videos related to
Sort By:
Page
of 35
Blood
|
April 25, 2025
A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed/refractory multiple myeloma
Sarah A Holstein, Shebli Atrash, Hira Mian, et al.
Haematologica
|
March 15, 2015
Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide
Michel Delforge, Leonard Minuk, Jean-Claude Eisenmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma
Ravi Vij, Shaji Kumar, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2024
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival
Marcelo C Pasquini, Paul K Wallace, Brent Logan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2009
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia
Alexander E Perl, Margaret T Kasner, Donald E Tsai, et al.
The Lancet. Oncology
|
October 4, 2011
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial
Amrita Krishnan, Marcelo C Pasquini, Brent Logan, et al.
Osteoarthritis and Cartilage
|
September 9, 2018
The role of NOX2-derived reactive oxygen species in collagenase-induced osteoarthritis
S C M van Dalen, N N L Kruisbergen, B Walgreen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2019
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Edward A Stadtmauer, Marcelo C Pasquini, Beth Blackwell, et al.
Leukemia
|
November 2, 2011
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
A Mahindra, M E Kalaycio, J Vela-Ojeda, et al.
Clinical Chemistry
|
August 12, 2021
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking
Hui Chen, Zhao Li, Sheng Feng, et al.
Page
of 35